• Je něco špatně v tomto záznamu ?

Driver and actionable mutations in younger patients with lung cancer - are we searching properly

M. Bratova, K. Brat, Z. Pavlovsky, J. Sana, O. Slaby

. 2023 ; 167 (2) : 152-156. [pub] 20230331

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23008942

AIMS: The authors focused on a group of young lung cancer patients with the aim of better understanding the mechanisms of tumor pathogenesis in these patients and search for potential targetable mutations. METHODS: We collected retrospective data on patients under 40 years diagnosed with lung cancer (NSCLC or small-cell lung cancer) from 2011-2020 at the Department of Respiratory Diseases, University Hospital Brno, Czech Republic. Tumor tissue of these patients was analysed by next-generation sequencing (NGS, a panel of 550 variants in 19 genes). Demographic characteristics, smoking history, histology, molecular-genetic results and clinical stage of the disesase were recorded in all eligible patients from accessible medical databases. RESULTS: Of 17 identified patients in only 8 cases was successful NGS carried out due to lack of sufficient good quality material in the other cases. The most frequently found molecular genetic changes were EGFR, RICTOR and HER2 amplification and MET and FGFR1 amplification. In addition, we found rare pathogenic variants in BRAF and PIK3CA genes. Actionable variants were detected in 75% patients. CONCLUSION: We detected very frequent driver and potentially actionable alterations in young patients with lung cancer. This suggests different mechanisms of carcinogenesis in these patients and indicates that they might benefit more from a specific approach than older lung cancer patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23008942
003      
CZ-PrNML
005      
20230802075203.0
007      
ta
008      
230707s2023 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2023.012 $2 doi
035    __
$a (PubMed)37009714
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Bratová, Monika $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0259129
245    10
$a Driver and actionable mutations in younger patients with lung cancer - are we searching properly / $c M. Bratova, K. Brat, Z. Pavlovsky, J. Sana, O. Slaby
520    9_
$a AIMS: The authors focused on a group of young lung cancer patients with the aim of better understanding the mechanisms of tumor pathogenesis in these patients and search for potential targetable mutations. METHODS: We collected retrospective data on patients under 40 years diagnosed with lung cancer (NSCLC or small-cell lung cancer) from 2011-2020 at the Department of Respiratory Diseases, University Hospital Brno, Czech Republic. Tumor tissue of these patients was analysed by next-generation sequencing (NGS, a panel of 550 variants in 19 genes). Demographic characteristics, smoking history, histology, molecular-genetic results and clinical stage of the disesase were recorded in all eligible patients from accessible medical databases. RESULTS: Of 17 identified patients in only 8 cases was successful NGS carried out due to lack of sufficient good quality material in the other cases. The most frequently found molecular genetic changes were EGFR, RICTOR and HER2 amplification and MET and FGFR1 amplification. In addition, we found rare pathogenic variants in BRAF and PIK3CA genes. Actionable variants were detected in 75% patients. CONCLUSION: We detected very frequent driver and potentially actionable alterations in young patients with lung cancer. This suggests different mechanisms of carcinogenesis in these patients and indicates that they might benefit more from a specific approach than older lung cancer patients.
590    __
$a
650    _2
$a lidé $7 D006801
650    _2
$a retrospektivní studie $7 D012189
650    12
$a nádory plic $x genetika $x patologie $7 D008175
650    12
$a nemalobuněčný karcinom plic $x genetika $7 D002289
650    12
$a malobuněčný karcinom plic $7 D055752
650    _2
$a mutace $7 D009154
655    _2
$a časopisecké články $7 D016428
700    1_
$a Brat, Kristián $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $u International Clinical Research Center, St. Anne ́s University Hospital, Brno, Czech Republic $7 xx0224637
700    1_
$a Pavlovský, Zdeněk, $u Department of Pathology, University Hospital Brno, Brno, Czech Republic $d 1971- $7 xx0136659
700    1_
$a Šána, Jiří $u Department of Pathology, University Hospital Brno, Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0165776
700    1_
$a Slabý, Ondřej, $u Department of Pathology, University Hospital Brno, Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $d 1981- $7 js20030220015
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 167, č. 2 (2023), s. 152-156
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37009714 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230802075159 $b ABA008
999    __
$a ok $b bmc $g 1964360 $s 1195205
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 167 $c 2 $d 152-156 $e 20230331 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK198 $a Pubmed-20230707

Najít záznam

Citační ukazatele

Možnosti archivace